Showing 1 – 4 of 4 results.
Curated
Restricted
Chicago Male Drug Use and Health Survey (MSM Supplement), 2002-2003 (ICPSR 34303)
Released/updated on: 2012-08-01
Geographic coverage: United States, Chicago, Illinois
Time period: 2002-09-01--2003-01-31
In recent years, club drugs such as MDMA, Ketamine, GHB, and Rohypnol have emerged as major drugs of abuse. The national and local Chicago news media have publicized law enforcement actions and adverse health outcomes, including fatalities, related to the abuse of these substances. Media accounts and a limited body of research have identified use of these substances as prevalent in the gay male community. This prevalence coincides with recent increases in HIV seropositive incidence. There is a clear need for a more comprehensive understanding of the prevalence of club drug use in the general population, and particularly in the subgroup of sexually active gay men. Noting these research gaps and their considerable adverse public health implications, this supplemental study was designed to apply an expanded protocol developed from an earlier study conducted (Feasibility and Use of Biological Measurement in Drug Surveys; R01DA12425, SRL Study #860) to a sample of gay men in the city of Chicago (Michael Fendrich, Principal Investigator). This study evaluated whether findings regarding the feasibility and use of drug testing in drug surveys derived from general population samples are generalizable to a probability sample of 216 gay men in the city of Chicago. For this project, a supplemental module was added to the main study survey that asked detailed questions about involvement in the gay community, risky sexual activity and HIV seropositivity. The scope of biological measurement was also expanded to incorporate testing for Rohypnol and Ketamine in hair (MDMA was already being tested as part of the general sample hair screen). The dataset contains 676 variables.
Curated
Cooperative Agreement for AIDS Community-Based Outreach/Intervention Research Program, 1992-1998: [United States] (ICPSR 3023)
Released/updated on: 2008-10-23
Geographic coverage: United States
Time period: 1992-01-01--1998-12-31
The purpose of the Cooperative Agreement (CA) Research Program was to monitor risk factors, risk behaviors, and rates of HIV seroprevalence and seroincidence among out-of-treatment, multi-ethnic/racial injection drug users and crack cocaine users. The program evaluated the efficacy of experimental interventions designed to prevent, eliminate, or reduce HIV risk behaviors and developed new treatment interventions. All participants received the standard intervention, which consisted of street-based outreach and HIV prevention counseling. Those assigned to enhanced interventions received more counseling sessions, educational videos, social gatherings, and support group activities. The public-use data file contains 31,088 respondent records, collected from 21 CA program facilities in the United States and one facility each in Puerto Rico and Brazil. Hence, the process data file contains 23 records of facility information that can be linked to individual respondents. Respondent interviews include a baseline Risk Behavior Assessment (completed prior to first intervention) and a Follow-Up Assessment, conducted either three months or six months after the baseline survey. Respondent data were augmented with eligibility information, biological markers of drug use, HIV test results, and intervention assignment. At baseline and post-intervention, the surveys measured drug use and drug treatment, sexual activity and sex for money/drugs, arrests, work/income, HIV/STD/pregnancy status, perceptions of risk, and risk reduction behaviors. The process questionnaires were completed by staff or principal investigators at the 23 site locations. Process data describe the program structure and process, other intervention projects in the community, needle exchange programs and pharmacy syringe sales, and local HIV infection rates. Drugs reported on include alcohol, marijuana/hashish, crack/cocaine, heroin (including speedball), non-prescription methadone, other opiates, and amphetamines.
Curated
Restricted
The Effectiveness of Coordinated Outreach in Intimate Partner Violence Cases in Denver, Colorado 2007 to 2009 (ICPSR 30961)
Released/updated on: 2014-11-07
Geographic coverage: United States, Colorado, Denver
Time period: 2007-01-01--2009-12-31
In collaboration with community- and system-based partners, the current study used an experimental design to test the impact of phone outreach from community-based agencies to women exposed to Intimate Partner Violence (IPV) compared to phone referrals provided by system-based unit (i.e., the Victim Assistance Unit of the DPD or the City Attorney's Office) in a racially and ethnically diverse sample of women whose cases have come to the attention of the criminal justice system. The phone outreach was informed by an interdisciplinary team involving both system- and community-based team members. Participants, who were randomly selected to receive outreach or treatment-as-usual, were interviewed at three time points: after an incident of IPV was reported to the police (T1), 6 months after T1, and 12 months after T1. The study addressed three primary roles. First, investigators evaluated the effectiveness of a coordinated, community-based outreach program in improving criminal justice and victim safety and empowerment outcomes for IPV victims using a longitudinal, randomized control design. Second, victim and case characteristics that moderated outcomes were identified. Third, the influence of spatial characteristics on criminal justice outcomes was evaluated.
Curated
Restricted
Strategic Prevention Framework State Incentive Grant (SPF SIG) National Cross-Site Evaluation [Restricted Use] (ICPSR 28921)
Released/updated on: 2014-03-24
Geographic coverage: North Carolina, Vermont, Indiana, United States, Wyoming, Tennessee, Maine, Arkansas, Washington, West Virginia, Colorado, Missouri, Guam, Arizona, Nevada, Rhode Island, Montana, Kentucky, Florida, Michigan, New Mexico, Illinois, Texas, Connecticut, New Hampshire, Louisiana, Palau
Time period: 2005-08-01--2007-09-30, 2006-12-14--2007-08-14, 2008-09-15--2009-06-30, 2008-10-15--2009-06-15, 2006-07-01--2006-09-30, 2005-12-01--2007-12-31, 2008-01-01--2008-06-30, 2008-07-01--2008-12-31, 2009-01-01--2009-06-30, 2009-07-01--2009-12-31, 2010-01-01--2010-06-30, 2005-12-01--2007-12-31, 2008-01-01--2008-06-30, 2008-07-01--2008-12-31, 2009-01-01--2009-06-30, 2009-07-01--2009-12-31, 2010-01-01--2010-06-30, 2005-12-01--2007-12-31, 2008-01-01--2008-06-30, 2008-07-01--2008-12-31, 2009-01-01--2009-06-30, 2009-07-01--2009-12-31, 2010-01-01--2010-06-30
The Strategic Prevention Framework State Incentive Grant (SPF SIG) National Cross-Site Evaluation was conducted to evaluate the Center for Substance Abuse Prevention (CSAP)'s SPF SIG initiative, which sought to: (1) prevent the onset and reduce the progression of substance abuse, including childhood and underage drinking; (2) reduce substance abuse-related problems in communities; and (3) build prevention capacity and infrastructure at the state and community levels. This cross-site evaluation included the 21 states and territories CSAP funded in FY2004 (Cohort 1) and an additional 5 States funded in Cohort 2 in FY2005 that were funded for up to 5 years to implement the SPF. The SPF is a five-step prevention planning model that requires states to: (1) conduct a statewide needs assessment, including the establishment of a State Epidemiological and Outcomes Workgroup (SEOW); (2) mobilize and build state and community capacity to address needs; (3) develop a statewide strategic plan for prevention; (4) implement evidence-based prevention, policies, and practices (EBPPP) to meet state and community needs; and (5) monitor and evaluate the implementation of their SPF SIG project. Under contract to the Substance Abuse and Mental Health Services Administration (SAMHSA) with funding provided by the National Institute on Drug Abuse (NIDA), Westat, in collaboration with the Pacific Institute for Research and Evaluation (PIRE) and The MayaTech Corporation, implemented a multilevel, multi-method quasi-experimental design to evaluate SPF SIG's impact. The scope of the evaluation encompassed national, state, and community levels. The design included comparison conditions at both the state and community levels. These data represent Phase I of the restricted use data release and contains extensive data on state-level implementation, community-level implementation, and state-level infrastructure, as well as other reference elements. A subsequent release (Phase II) will include state- and community-level outcomes, as well as data on community-level implementation, community-level implementation fidelity, state-level sustainability, and mediating variables.